Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 16.625 GBX 3.1% Market Closed
Market Cap: 68.5m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-3.2
Current
-5.6
Median
12.8
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-3.2
=
Enterprise Value
69.4m GBX
/
EBITDA
-21.6m GBP
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-3.5
2-Years Forward
EV/EBITDA
-4.3
3-Years Forward
EV/EBITDA
-6.5

See Also

Discover More